Priority Date: 07.10.11 (US 201113269365)

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENETIC SIGNATURE

  • Application ID: EP12772695
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 2003
Headquarter in Mannheim and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 07.10.2011 - Priority Date (US 201113269365)
  • 11.04.2013 - Publication A1 (WO2013052719)
  • 02.07.2014 - Publication A1 (EP2747766)